Patient Education on Labor Analgesia Options

Status Completed

Clinical Trial Summary

The purpose of this study is to learn how the investigators can better educate pregnant patients about the options open to them for pain relief during labor. Patients will receive educational pamphlet during prenatal clinic visit and again on admission to labor and delivery. The options for analgesia will be discussed by anesthesia care provider. Patient will be asked to complete a survey on the post partum unit.

Clinical Trial Description

Many analgesic options exist for laboring parturients, but labor may not be the best time to start informing patients of their options. Many patients begin the labor process with a plan in place for their analgesia. Unfortunately, internet resources regarding labor analgesia that are available to the lay parturient are poor and often lead to misconceptions about the options and their risks. A significant number of patients refuse neuraxial analgesia based on misunderstandings, concerns about the procedure, or a lack of faith in the provider. Some women want a "natural childbirth" and/or control over their labor experience. Our study aimed at providing information and alternatives for labor analgesia in a simple written format.

The investigators will provide information of available labor analgesia options (epidural, combined spinal/epidural, spinal, remifentanil patient-controlled analgesia, and intravenous opioids) to expecting mothers. Using a pamphlet written in English or Spanish disseminated to pregnant women in clinic and upon arrival in the labor and delivery unit, the procedures and their risks and benefits will be explained in simple terms. In the Labor and Delivery Unit the patients will have an opportunity to ask questions of the anesthesia care giver regarding the options for analgesia. After delivery while on F Green, patients will be asked to complete a questionnaire addressing their thoughts about the pamphlets and their overall satisfaction with their labor analgesia. The analysis will focus on the utility and effect of education materials on maternal informed consent for labor analgesia, on maternal choice of analgesia modality, and on maternal anxiety regarding their labor analgesia plan. ;

Study Design

Related Conditions & MeSH terms

Labor Analgesia

Clinical Trial Details

NCT number	NCT02557555
Study type	Observational
Source	Rutgers, The State University of New Jersey
Contact
Status	Completed
Phase
Start date	September 2015
Completion date	March 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02873091` - Comparison of Programmed Intermittent Epidural Bolus With Continuous Epidural Infusion for Labor Epidural Analgesia	N/A
Recruiting	`NCT00954317` - Do Epidurals Placed at a Lower Level Improve Labor Analgesia?	N/A
Recruiting	`NCT05990504` - The Effect of Dural Puncture Epidural Block Technique on the Effectiveness and Safety of Labor Analgesia	N/A
Completed	`NCT03366935` - Combined Implementation of Dural Puncture Epidural and Programmed Intermittent Epidural Bolus for Labor Analgesia	N/A
Completed	`NCT04759547` - Handheld Ultrasound-assisted Versus Palpation-guided Labor Combined Spinal-epidural Analgesia	N/A
Not yet recruiting	`NCT02708602` - Correlation Between the Polymorphism ofβ2 AR and the Labor Progress After Labor Analgesia	N/A
Recruiting	`NCT04992663` - Investigating the Effect of Virtual Reality on Labour Analgesia Use	N/A
Recruiting	`NCT05666024` - A Clinical Study on the Effect of Labor Analgesia on the Postpartum Recovery Outcome of Chinese Parturients
Completed	`NCT03980951` - Neuroaxial Labour Analgesia	N/A
Completed	`NCT02412969` - Impact of Dural Puncture Epidural Versus Traditional Lumbar Epidural on Onset of Labor Analgesia	N/A
Not yet recruiting	`NCT05909085` - The Impact of Needle Manipulation and Accuracy Between Hand Held Automatic and Traditional Ultrasound Device	N/A
Recruiting	`NCT06300151` - The Effect of Ultrasound Real-time Guidance Technique on the Effectiveness and Safety of Labor Analgesia	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.